Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

1.4K
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
1.4K
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

6.3K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
6.3K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

764
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
764
Pneumothorax-II01:27

Pneumothorax-II

1.7K
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
1.7K
Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

1.2K
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
1.2K
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

759
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
759

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CellVizio<sup>®</sup> System for Mesothorax Lymphadenopathy Rapid on Site, 18G needle: Pros and Cons.

Journal of Cancer·2026
Same author

Asthma-free eosinophilic granulomatosis with polyangiitis presenting with Guillain-Barré syndrome-like symptoms: a case report.

Frontiers in medicine·2026
Same author

Macroscopic on-site evaluation based on core tissues length and weight during EBUS-TBNA using 22-gauge needles.

Chinese medical journal·2026
Same author

Exploration into the structural characteristics and functional properties of exopolysaccharide synthesized by Pseudoduganella armeniaca ZMN-3.

International journal of biological macromolecules·2026
Same author

Hemoadsorption combined with hemodialysis versus hemodialysis alone on mortality in end-stage kidney disease: a randomized, open-label, multicenter trial.

Nature communications·2026
Same author

ACOD1-itaconate in macrophage attenuates oxidative stress and inflammation in benign airway stenosis by upregulating and transferring FTH1.

Redox biology·2026
Same journal

From contraindication to consideration: the role of esophagectomy in stage IV esophageal adenocarcinoma.

Journal of thoracic disease·2026
Same journal

Clinical features and prognostic factor of small (≤2 cm) lung cancer associated with cystic airspaces.

Journal of thoracic disease·2026
Same journal

Sex-specific trends in incidence and mortality of interstitial lung disease and pulmonary sarcoidosis in China compared with global estimates, 1990-2023: an analysis of GBD 2023.

Journal of thoracic disease·2026
Same journal

A single-arm, single-center phase II clinical study of concurrent brain radiotherapy combined with tislelizumab and chemotherapy in patients with small-cell lung cancer and brain metastases.

Journal of thoracic disease·2026
Same journal

Minimally invasive off-pump coronary artery bypass grafting is associated with reduced postoperative intra-aortic balloon pump use.

Journal of thoracic disease·2026
Same journal

Pulmonary artery involvement contributes to the recurrence of hemoptysis after bronchial artery embolization in patients with chronic pulmonary aspergillosis.

Journal of thoracic disease·2026
See all related articles

Related Experiment Video

Updated: May 7, 2026

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
03:22

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion

Published on: November 10, 2023

2.3K

Malignant pleural effusion and algorithm management.

Konstantinos Zarogoulidis1, Paul Zarogoulidis, Kaid Darwiche

  • 1Pulmonary Department-Oncology Unit, "G. Papanikolaou" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece;

Journal of Thoracic Disease
|October 9, 2013
PubMed
Summary
This summary is machine-generated.

Malignant pleural effusion (MPE) in lung cancer patients significantly reduces life expectancy. Talc pleurodesis is the preferred treatment for chemotherapy-resistant MPE, aiming to improve quality of life.

Keywords:
Malignant pleural effusion (MPE)pleurodesissuicide gene therapythoracoscopy

More Related Videos

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

6.3K
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

1.6K

Related Experiment Videos

Last Updated: May 7, 2026

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
03:22

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion

Published on: November 10, 2023

2.3K
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

6.3K
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

1.6K

Area of Science:

  • Oncology
  • Pulmonology
  • Thoracic Surgery

Background:

  • Pleural involvement in lung cancer is common, often reducing life expectancy.
  • Malignant pleural effusion (MPE) management focuses on symptom relief and improving quality of life.
  • Histological confirmation is crucial for effective patient management.

Purpose of the Study:

  • To outline optimal management strategies for malignant pleural effusion in lung cancer patients.
  • To highlight the role of pleurodesis in improving quality of life for patients with chemotherapy-resistant MPE.

Main Methods:

  • Review of management strategies for malignant pleural effusion.
  • Discussion of thoracentesis, intercostal tube drainage, and pleurodesis (thoracoscopic or indwelling catheter).
  • Emphasis on talc pleurodesis (poudrage or slurry) as a primary treatment.

Main Results:

  • Talc pleurodesis remains the treatment of choice for chemotherapy-resistant MPE.
  • Procedures like thoracentesis and drainage are initial steps.
  • Pleurodesis aims to prevent fluid re-accumulation and improve patient well-being.

Conclusions:

  • For lung cancer patients with MPE and a life expectancy over 3 months, resistant to chemotherapy, talc pleurodesis is the recommended intervention.
  • Effective management of MPE is key to enhancing the quality of life for these patients.
  • Talc pleurodesis, utilizing sterile, asbestos-free talc, is a well-established and effective procedure.